Home/Regentis Biomaterials/Dr. Shai Meretzki
DS

Dr. Shai Meretzki

Former Chief Executive Officer and Director

Regentis Biomaterials

Regentis Biomaterials Pipeline

DrugIndicationPhase
GelrinCFocal cartilage defects of the knee (osteochondral lesions)Phase 2
GelrinS / Platform DerivativesWound Healing (e.g., Diabetic Foot Ulcers)Pre-clinical